This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirabayashi, K. Articles by Irimura, T. Search for Related Content PubMed PubMed Citation Articles by Hirabayashi, K. Articles by Irimura, T.

Inhibition of Cancer Cell Growth by Polyinosinic-Polycytidylic Acid/Cationic Liposome Complex: A New Biological Activity

Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., Kyoto, 601-8550 [K. H., J. Y., T. In., T. Y., K. T., G. E. S., K. I., T. O., K. K.]; and Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, 113-0033 [T. Ir.], Japan

A complex of polyinosinic-polycytidylic acid [poly(I)•poly(C)] and cationic liposome (LIC) inhibited the growth of many tumor cell lines at low concentration in vitro, but poly(I)•poly(C) alone had no such antiproliferative effect. The IC₅₀ values of LIC against the tumor cells ranged from 0.1 to 1000 ng/ml. LIC had strong cytotoxic effects on malignant cells of epithelial and fibroblastic origin from various tissues and was also effective against Adriamycin-resistant tumor cells. LIC did not significantly affect the growth of lymphoma cells, leukemia cells, normal diploid fibroblasts, or primary liver cells at concentrations up to 10 µg/ml. The mechanism of the antiproliferative effect of LIC against malignant cells was the induction of apoptosis. LIC induced the fragmentation of nuclear DNA and the degradation of rRNA in tumor cells. The DNA fragmentation occurred within 1–5 h after the addition of LIC, and both the fragmentation and the inhibition of cancer-cell growth were suppressed by a nuclease inhibitor. In contrast, caspase inhibitors did not affect the antiproliferative activity of LIC. These results suggest that LIC induced apoptosis in malignant cells through the direct activation of nucleases and not through the activation of caspases. LIC reduced the incidence and the size of metastatic liver-cancer tumors in two different mouse metastatic liver-cancer models using human colon carcinoma cells. Histochemical analysis revealed that the KM12-HX cells in the tumor nodules were undergoing apoptosis; therefore, LIC also induced the apoptosis of tumor cells in vivo. In these animal models, LIC caused no observed changes in normal hepatocytes.

This article has been cited by other articles:

				D. M. Lim, S. Narasimhan, C. Z. Michaylira, and M.-L. Wang TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells Am J Physiol Gastrointest Liver Physiol, December 1, 2009; 297(6): G1172 - G1180. [Abstract] [Full Text] [PDF]

				S. Sonoke, T. Ueda, K. Fujiwara, Y. Sato, K. Takagaki, K. Hirabayashi, T. Ohgi, and J. Yano Tumor Regression in Mice by Delivery of Bcl-2 Small Interfering RNA with Pegylated Cationic Liposomes Cancer Res., November 1, 2008; 68(21): 8843 - 8851. [Abstract] [Full Text] [PDF]

				T. Uno, K. Hirabayashi, M. Murai, J. Yano, and K. Ozato The role of IFN regulatory factor-3 in the cytotoxic activity of NS-9, a polyinosinic-polycytidylic acid/cationic liposome complex, against tumor cells Mol. Cancer Ther., May 1, 2005; 4(5): 799 - 805. [Abstract] [Full Text] [PDF]

				J. Yano, K. Hirabayashi, S.-i. Nakagawa, T. Yamaguchi, M. Nogawa, I. Kashimori, H. Naito, H. Kitagawa, K. Ishiyama, T. Ohgi, et al. Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer Clin. Cancer Res., November 15, 2004; 10(22): 7721 - 7726. [Abstract] [Full Text] [PDF]